Ginsenoside Rg2
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Ginsenoside Rg2
Description:
Ginsenoside Rg2 is one of the major active components of ginseng. Ginsenoside Rg2 inhibits VCAM-1 and ICAM-1 expressions stimulated with lipopolysaccharide (LPS) . Ginsenoside Rg2 also reduces Aβ1-42 accumulation.Product Name Alternative:
Chikusetsusaponin I; Panaxoside Rg2; Prosapogenin C2UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Amyloid-β; NF-κBType:
Natural ProductsRelated Pathways:
Neuronal Signaling; NF-κBApplications:
Cancer-programmed cell deathField of Research:
Neurological Disease; Cardiovascular Disease; CancerAssay Protocol:
https://www.medchemexpress.com/Ginsenoside-Rg2.htmlPurity:
98.11Solubility:
DMSO : 50 mg/mL (ultrasonic)Smiles:
C[C@]([C@@](C[C@H]1O)([H])[C@]2(CC[C@@H]3O)C)(C[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]4O)([H])[C@@H]4O[C@@](O[C@@H](C)[C@H](O)[C@H]5O)([H])[C@@H]5O)[C@@]2([H])C3(C)C)[C@]6([C@@]1([H])[C@]([C@@](C)(O)CC/C=C(C)/C)([H])CC6)CMolecular Formula:
C42H72O13Molecular Weight:
785.01Precautions:
H302, H315, H319, H335References & Citations:
[1]Cho YS, et al. Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell. Korean J Physiol Pharmacol. 2013 Apr;17 (2) :133-7.|[2]Li N, et al. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease. J Ginseng Res. 2016 Jan;40 (1) :9-17.|[3]Cho YS, et al. Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell. Korean J Physiol Pharmacol. 2013;17 (2) :133-137.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
NF-κBCAS Number:
[52286-74-5]
